These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18562401)

  • 1. The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment: Curacao extrapyramidal syndromes study IX.
    Wilffert B; Al Hadithy AF; Sing VJ; Matroos G; Hoek HW; van Os J; Bruggeman R; Brouwers JR; van Harten PN
    J Psychopharmacol; 2009 Aug; 23(6):652-9. PubMed ID: 18562401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia.
    Al Hadithy AF; Ivanova SA; Pechlivanoglou P; Semke A; Fedorenko O; Kornetova E; Ryadovaya L; Brouwers JR; Wilffert B; Bruggeman R; Loonen AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):475-81. PubMed ID: 19439249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients.
    Gunes A; Scordo MG; Jaanson P; Dahl ML
    Psychopharmacology (Berl); 2007 Mar; 190(4):479-84. PubMed ID: 17102980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients.
    Liou YJ; Liao DL; Chen JY; Wang YC; Lin CC; Bai YM; Yu SC; Lin MW; Lai IC
    Neuromolecular Med; 2004; 5(3):243-51. PubMed ID: 15626824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia.
    Basile VS; Ozdemir V; Masellis M; Meltzer HY; Lieberman JA; Potkin SG; Macciardi FM; Petronis A; Kennedy JL
    Mol Psychiatry; 2001 Mar; 6(2):230-4. PubMed ID: 11317228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia.
    Segman RH; Heresco-Levy U; Finkel B; Goltser T; Shalem R; Schlafman M; Dorevitch A; Yakir A; Greenberg D; Lerner A; Lerer B
    Mol Psychiatry; 2001 Mar; 6(2):225-9. PubMed ID: 11317227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine.
    Gunes A; Melkersson KI; Scordo MG; Dahl ML
    J Clin Psychopharmacol; 2009 Feb; 29(1):65-8. PubMed ID: 19142110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of parkinsonism, rigidity, rest tremor, and bradykinesia in African-Caribbean inpatients: differences in association with dopamine and serotonin receptors.
    Al Hadithy AF; Wilffert B; Stewart RE; Looman NM; Bruggeman R; Brouwers JR; Matroos GE; van Os J; Hoek HW; van Harten PN
    Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):890-7. PubMed ID: 18389501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility.
    Segman RH; Heresco-Levy U; Finkel B; Inbar R; Neeman T; Schlafman M; Dorevitch A; Yakir A; Lerner A; Goltser T; Shelevoy A; Lerer B
    Psychopharmacology (Berl); 2000 Nov; 152(4):408-13. PubMed ID: 11140333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients.
    Liao DL; Yeh YC; Chen HM; Chen H; Hong CJ; Tsai SJ
    Neuropsychobiology; 2001; 44(2):95-8. PubMed ID: 11490179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evidence for the association between 5-HT2C receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patients.
    Gunes A; Dahl ML; Spina E; Scordo MG
    Eur J Clin Pharmacol; 2008 May; 64(5):477-82. PubMed ID: 18205001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia.
    Chong SA; Tan EC; Tan CH; Mythily ; Chan YH
    Am J Med Genet B Neuropsychiatr Genet; 2003 Jan; 116B(1):51-4. PubMed ID: 12497614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive dyskinesia and DRD2, DRD3, DRD4, 5-HT2A variants in schizophrenia: an association study with repeated assessment.
    Lattuada E; Cavallaro R; Serretti A; Lorenzi C; Smeraldi E
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):489-93. PubMed ID: 15383158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients.
    Zai CC; Hwang RW; De Luca V; Müller DJ; King N; Zai GC; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Kennedy JL
    Int J Neuropsychopharmacol; 2007 Oct; 10(5):639-51. PubMed ID: 16959057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia.
    Basile VS; Masellis M; Badri F; Paterson AD; Meltzer HY; Lieberman JA; Potkin SG; Macciardi F; Kennedy JL
    Neuropsychopharmacology; 1999 Jul; 21(1):17-27. PubMed ID: 10379516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients.
    Steen VM; Løvlie R; MacEwan T; McCreadie RG
    Mol Psychiatry; 1997 Mar; 2(2):139-45. PubMed ID: 9106238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype.
    Lerer B; Segman RH; Tan EC; Basile VS; Cavallaro R; Aschauer HN; Strous R; Chong SA; Heresco-Levy U; Verga M; Scharfetter J; Meltzer HY; Kennedy JL; Macciardi F
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):411-25. PubMed ID: 15857569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serotonin 2A receptor and lack of association of CYP1A2 gene polymorphism with tardive dyskinesia in a Turkish population.
    Boke O; Gunes S; Kara N; Aker S; Sahin AR; Basar Y; Bagci H
    DNA Cell Biol; 2007 Aug; 26(8):527-31. PubMed ID: 17688403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia.
    Lai IC; Mo GH; Chen ML; Wang YC; Chen JY; Liao DL; Bai YM; Lin CC; Chen TT; Liou YJ
    Eur J Clin Pharmacol; 2011 Apr; 67(4):383-388. PubMed ID: 21181138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.